Dihexa
Dihexa (PNB-0408) is a synthetic angiotensin-IV analogue studied within neurotrophic and hepatocyte-growth-factor (HGF/c-Met) research pathways. Supplied in pre-portioned capsule format with every batch independently verified.
What is Dihexa?
Dihexa is a synthetic small-molecule angiotensin-IV analogue. It is supplied here in capsule format for laboratory research use only.
Areas of research interest
Published preclinical research has explored Dihexa in connection with:
- Hepatocyte-growth-factor (HGF/c-Met) signalling research
- Neurotrophic and synaptogenesis research in animal models
- Angiotensin-IV analogue structure-activity research
Research context
Laboratory and animal studies have investigated Dihexa in connection with HGF/c-Met signalling and neurotrophic research pathways. These observations are derived from preclinical research and have not been established in humans. This information is provided solely as a research reference.
Specifications
- Compound: N-hexanoic-Tyr-Ile-(6) aminohexanoic amide
- Format: capsules, 10 mg per capsule
- Purity: ≥98% by HPLC
- Molecular weight: 535.7 g/mol
- Storage: cool, dry, away from light
- Research use only
Quality Assurance
Every Syngeve compound is independently tested and supplied with a certificate of analysis. Average purity 99%+. Each batch undergoes third-party HPLC and mass-spectrometry verification before dispatch.
Certificate of Analysis
A batch-specific certificate of analysis is included with every order.
Shipping
Dispatched within 24 hours in discreet, tamper-evident packaging.
For research purposes only, where permitted by local regulations. Not for human consumption. This product is not a medicine and is not intended to diagnose, treat, cure, or prevent any disease.
